-transparent.png){kind=logo}
The scope of this short review is to summarise the knowledge gleaned from the fate of drugs transported by albumin upon contact with the target cancer cell or cells in inflamed tissues. The authors expertise covers covalently bound drugs and their cellular uptake and release from albumin. This review therefore aims to deduce what will happen to drugs such as insulin detemir which is considered to bind non-covalently to albumin and may have a fate similar to fatty acids transported by albumin.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Eva Frei
December 2001,
American journal of physiology. Lung cellular and molecular physiology,
Eva Frei
January 1992,
European journal of clinical pharmacology,
Eva Frei
March 1974,
Nature,
Eva Frei
March 1986,
The Journal of clinical investigation,
Eva Frei
January 1980,
Endocrinology,
Eva Frei
August 2019,
Science advances,
Eva Frei
October 1989,
The American journal of physiology,
Eva Frei
August 1984,
Biochimica et biophysica acta,
Eva Frei
December 2008,
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,
Eva Frei
January 2001,
American journal of kidney diseases : the official journal of the National Kidney Foundation,
